Rockwell Medical (RMTI) Tops Q3 EPS by 5c, provides guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $0.67 --0%
EPS Growth %: -200.0%
Financial Fact:
Income (Loss) Before Income Taxes: -4.56M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -200.0%
Financial Fact:
Income (Loss) Before Income Taxes: -4.56M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q3 EPS of $0.00, $0.05 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $15.9 million versus the consensus estimate of $16.18 million.
GUIDANCE:
Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $68.374 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
